NK Cells in Cancer Immunotherapy: Successes and Challenges NK Cells in Cancer Immunotherapy: Successes and Challenges
Sensitizing Agents for Cancer Resistant to Cell Mediated Immunotherapy

NK Cells in Cancer Immunotherapy: Successes and Challenges

    • £139.99
    • £139.99

Publisher Description

NK Cells in Cancer Immunotherapy: Successes and Challenges explains the latest immunotherapeutic strategies, focusing on NK cells to allow the best and precise combination treatments to cancer patients. The book provides existing background knowledge in the field of immunotherapy and discusses future areas of research required to carry out cutting-edge, validated therapies. Chapters cover advances in immunotherapeutic strategies, in particular, the use of NK cells with and without T-cell therapy in the treatment of cancer. The book is a valuable resource for cancer researchers, oncologists, graduate students and those interested in learning more about novel strategies to treat cancer patients.

Immunotherapy is fast becoming the method of choice for cancer therapy. Although remarkable advances have been made in the field of immunotherapy, there are significant challenges and difficulties ahead since many of the current immunotherapeutic strategies do not provide long-lasting treatment strategies, and therefore are not very effective. Covers CAR/T and CAR/NK and adoptive NK cell therapy with and without T cell therapies Discusses basic biology of NK cells and mouse models of human cancers and the role of NK cells in metastatic cancer and in cancer stem cells Encompasses information on combination therapies using check point inhibition, adoptive transfer of cytotoxic effector cells, chemotherapeutic drugs and activating and inhibitory antibodies

GENRE
Science & Nature
RELEASED
2022
6 December
LANGUAGE
EN
English
LENGTH
494
Pages
PUBLISHER
Elsevier Science
SIZE
34.4
MB

More Books Like This

Successes and Challenges of NK Immunotherapy (Enhanced Edition) Successes and Challenges of NK Immunotherapy (Enhanced Edition)
2021
New Targeting in The Reversal of Resistant Glioblastomas (Enhanced Edition) New Targeting in The Reversal of Resistant Glioblastomas (Enhanced Edition)
2021
Improving the Therapeutic Ratio in Head and Neck Cancer Improving the Therapeutic Ratio in Head and Neck Cancer
2019
Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies (Enhanced Edition) Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies (Enhanced Edition)
2021
Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 1 Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 1
2014
Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance
2020

More Books by Anahid Jewett & Yuman Fong MD, FACS

Other Books in This Series

Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives
2020
Autophagy in Immune Response: Impact on Cancer Immunotherapy Autophagy in Immune Response: Impact on Cancer Immunotherapy
2020
Immunotherapeutic Strategies for the Treatment of Glioma Immunotherapeutic Strategies for the Treatment of Glioma
2021